Research analysts at StockNews.com started coverage on shares of Veradigm (NASDAQ:MDRX - Get Free Report) in a research note issued to investors on Sunday. The firm set a "hold" rating on the software maker's stock.
Veradigm Stock Down 1.4 %
Shares of MDRX stock traded down $0.15 during trading hours on Friday, reaching $10.66. The stock had a trading volume of 70,633 shares, compared to its average volume of 463,594. The firm has a 50-day simple moving average of $9.62 and a 200-day simple moving average of $9.34. Veradigm has a twelve month low of $5.01 and a twelve month high of $12.86.
Institutional Investors Weigh In On Veradigm
A hedge fund recently bought a new stake in Veradigm stock. Innealta Capital LLC bought a new stake in shares of Veradigm Inc. (NASDAQ:MDRX - Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund bought 3,974 shares of the software maker's stock, valued at approximately $38,000.
About Veradigm
(
Get Free Report)
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Featured Articles
Before you consider Veradigm, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Veradigm wasn't on the list.
While Veradigm currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
